This week's Fierce Cell & Gene is brought to you by Thermo Fisher Scientific.
Join us for an informative panel-based webinar for insights from Thermo Fisher Scientific technical, quality and regulatory experts to help optimize your manufacturing strategy for plasmid DNA.
- Update on cell and gene therapy market trends and approvals
- Latest regulatory recommendations on use of GMP raw materials in advanced therapy manufacturing processes
- Guidance on application of GMP principles for plasmid manufacturing using a risk-based approach
- Suggestions for cell and gene therapy innovators to accelerate timelines and mitigate risk
|
| You are currently subscribed as newsletter@newslettercollector.com |
